Photodynamic Therapy Using a Protease-Mediated Theranostic Agent Reduces Cathepsin-B Activity in Mouse Atheromata In Vivo

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Arteriosclerosis, Thrombosis and Vascular Biology

• Publication date

  2013-06-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1161/ATVBAHA.113.301290PMID 23539220
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Inflammation in Atherosclerosis

  2012influential reference
• Atorvastatin and clopidogrel interfere with photosensitization in vitro

  2011influential reference
• Intra-arterial catheter for simultaneous microstructural and molecular imaging in vivo

  2011cited by this paper
• Exercise attenuates matrix metalloproteinase activity in preexisting atherosclerotic plaque.

  2011cited by this paper
• Protease Imaging of Human Atheromata Captures Molecular Information of Atherosclerosis, Complementing Anatomic Imaging

  2010cited by this paper
• A light-activated theranostic nanoagent for targeted macrophage ablation in inflammatory atherosclerosis.

  2010cited by this paper
• Will Molecular Optical Imaging Have Clinically Important Roles in Stroke Management, and How?

  2010cited by this paper
• Pharmacological Inhibition of C-C Chemokine Receptor 2 Decreases Macrophage Infiltration in the Aortic Root of the Human C-C Chemokine Receptor 2/Apolipoprotein E−/− Mouse: Magnetic Resonance Imaging Assessment

  2010cited by this paper
• Molecular Imaging of Cathepsin B Proteolytic Enzyme Activity Reflects the Inflammatory Component of Atherosclerotic Pathology and Can Quantitatively Demonstrate the Antiatherosclerotic Therapeutic Effects of Atorvastatin and Glucosamine

  2009cited by this paper
• Tumor specificity and therapeutic efficacy of photosensitizer-encapsulated glycol chitosan-based nanoparticles in tumor-bearing mice.

  2009cited by this paper
• New light on an old problem photodynamic therapy for atherosclerosis.

  2008influential reference
• PhotoPoint photodynamic therapy promotes stabilization of atherosclerotic plaques and inhibits plaque progression.

  2008cited by this paper
• Cathepsin cysteine proteases in cardiovascular disease

  2007cited by this paper
• Optical Visualization of Cathepsin K Activity in Atherosclerosis With a Novel, Protease-Activatable Fluorescence Sensor

  2007influential reference
• Selective antitumor effect of novel protease-mediated photodynamic agent.

  2006influential reference
• Inflammation in Atherosclerosis: Visualizing Matrix Metalloproteinase Action in Macrophages In Vivo

  2006influential reference
• [Morphological aspects of atherosclerosis lesion: past and present].

  2006cited by this paper
• Mechanisms of plaque vulnerability and rupture.

  2003cited by this paper
• Inflammation in atherosclerosis

  2002cited by this paper
• Photodynamic Therapy With Motexafin Lutetium Induces Redox-Sensitive Apoptosis of Vascular Cells

  2001cited by this paper
• Photodynamic therapeutics: basic principles and clinical applications.

  1999cited by this paper
• Comprehensive observational assessment: Ia. A systematic, quantitative procedure for assessing the behavioral and physiologic state of the mouse

  1968cited by this paper

• The Essence of Lipoproteins in Cardiovascular Health and Diseases Treated by Photodynamic Therapy

  2024cites this paper
• Nano Revolution in Cardiovascular Health: Nanoparticles (NPs) as Tiny Titans for Diagnosis and Therapeutics.

  2024cites this paper
• Macrophage-mannose-receptor-targeted photoactivatable agent for in vivo imaging and treatment of atherosclerosis.

  2024cites this paper
• Photodynamic Therapy and Cardiovascular Diseases

  2024cites this paper
• Targeting macrophages with multifunctional nanoparticles to detect and prevent atherosclerotic cardiovascular disease

  2024cites this paper
• Cathepsin B in cardiovascular disease: Underlying mechanisms and therapeutic strategies

  2024cites this paper
• Recent Advances for Dynamic-Based Therapy of Atherosclerosis

  2023cites this paper
• Multifunctional role of nanoparticles for the diagnosis and therapeutics of cardiovascular diseases.

  2023cites this paper
• Overview of multifunctional cysteinyl cathepsins in atherosclerosis-based cardiovascular disease: from insights into molecular functions to clinical implications

  2023cites this paper
• Atherosclerosis treatment with nanoagent: potential targets, stimulus signals and drug delivery mechanisms

  2023cites this paper
• Activity-Based Probes for Proteases Pave the Way to Theranostic Applications

  2022cites this paper
• Chemiexcited Photodynamic Therapy Integrated in Polymeric Nanoparticles Capable of MRI Against Atherosclerosis

  2022cites this paper
• Recent advances in targeted stimuli-responsive nano-based drug delivery systems combating atherosclerosis

  2021cites this paper
• Nanomaterials as Novel Cardiovascular Theranostics

  2021cites this paper
• Molecular probes for selective detection of cysteine cathepsins.

  2021cites this paper
• A critical approach to nanocardiology

  2021cites this paper
• Targeted theranostic photoactivation on atherosclerosis

  2021influential citation
• Stimulus‐Responsive Nanoparticles for Therapeutic Stabilization of Atherosclerosis

  2021cites this paper
• Cathepsin B-responsive nanodrug delivery systems for precise diagnosis and targeted therapy of malignant tumors

  2020cites this paper
• Nanomaterial-Mediated Theranostics for Vascular Diseases

  2020cites this paper
• Nanoparticle-Mediated Drug Delivery for the Treatment of Cardiovascular Diseases

  2020cites this paper
• Oxidative Stress and Photodynamic Therapy of Skin Cancers: Mechanisms, Challenges and Promising Developments

  2020cites this paper
• Applications of inorganic nanoparticles in the diagnosis and therapy of atherosclerosis.

  2020cites this paper
• Treatment of atherosclerotic plaque: perspectives on theranostics

  2019cites this paper
• Cardiovascular Imaging and Theranostics in Cardiovascular Pharmacotherapy

  2019cites this paper
• Advanced Photosensitizer Activation Strategies for Smarter Photodynamic Therapy Beacons.

  2019cites this paper
• Porphyrin Molecular Beacons – a New Approach to Osteoarthritis

  2019cites this paper
• A Theranostic Cathepsin Activity-Based Probe for Noninvasive Intervention in Cardiovascular Diseases

  2019cites this paper
• Atherosclerosis Treatment with Stimuli‐Responsive Nanoagents: Recent Advances and Future Perspectives

  2019cites this paper
• Combination of NIR therapy and regulatory T cell modulation using layer-by-layer hybrid nanoparticles for effective cancer photoimmunotherapy

  2018cites this paper
• Molecular Imaging in Drug Discovery and Development.

  2018cites this paper
• Photodynamic therapy for the treatment of atherosclerotic plaque: Lost in translation?

  2017cites this paper
• The Future of Cysteine Cathepsins in Disease Management.

  2017cites this paper
• 13 Tumor-specific imaging and photodynamic therapy targeting the urokinase receptor

  2017cites this paper
• Cysteine proteases in atherosclerosis

  2017cites this paper
• Recent strategies to design vascular theranostic nanoparticles

  2017cites this paper
• pH- and Thiol-Responsive BODIPY-Based Photosensitizers for Targeted Photodynamic Therapy.

  2016cites this paper
• Pathophysiological relevance of macrophage subsets in atherogenesis

  2016cites this paper
• Macrophage Targeted Theranostics as Personalized Nanomedicine Strategies for Inflammatory Diseases

  2015cites this paper
• Direct Imaging of Cerebral Thromboemboli Using Computed Tomography and Fibrin-targeted Gold Nanoparticles

  2015cites this paper
• Macrophage COX-2 As a Target For Imaging And Therapy of Inflammatory Diseases Using Theranostic Nanoemulsions

  2015cites this paper
• Photodynamic Quenched Cathepsin Activity Based Probes for Cancer Detection and Macrophage Targeted Therapy

  2015cites this paper
• Recent Highlights of ATVB

  2014cites this paper
• Nanomedicine-based strategies for treatment of atherosclerosis.

  2014cites this paper
• Proteinases and plaque rupture: unblocking the road to translation

  2014cites this paper
• Hyaluronic acid-polypyrrole nanoparticles as pH-responsive theranostics.

  2014cites this paper
• Selective ablation of β-galactosidase-expressing cells with a rationally designed activatable photosensitizer.

  2014cites this paper
• Molecular Imaging: Concepts and Applications in Cardiovascular Disease

  2014cites this paper
• Nouvelles Voies de Régulation contrôlant l'Homéostasie Lipidique et l'Inflammation dans le Macrophage Humain au cours de l'Athérosclérose

  2014cites this paper
• Macrophages

  2014cites this paper
• ROS-Responsive Activatable Photosensitizing Agent for Imaging and Photodynamic Therapy of Activated Macrophages

  2013cites this paper
• Mallat Recent Highlights : Macrophages 2511

  year unknowncites this paper